Navigation Links
NxStage Appoints New Member to Its Board of Directors and Announces Resignation of Board Member
Date:10/28/2008

LAWRENCE, Mass., Oct. 28 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the addition of Earl R. Lewis to the Company's Board of Directors and the resignation of Peter P. Phildius from the Board.

"I first want to thank Pete for the contributions he has made to the Company. I have benefited greatly from working closely with him over the last 10 years. We look forward to working with Earl and leveraging his extensive business experience," said Jeff Burbank, Chief Executive Officer of NxStage Medical. "His record of successes with high growth technology companies will be of significant value to us as we continue to expand our business."

Mr. Lewis is the current Chairman, President and CEO of Flir Systems Inc. (NYSE: FLIR), a manufacturer of thermal imaging and infrared camera systems. Previously, he served as CEO and President at Thermo Instrument Systems, Inc. He also served Thermo in various executive capacities, including President and Chief Operating Officer, CEO and President of Thermo Optek Corp., and President of Thermo Jarrell Ash Corp. Mr. Lewis is also a member of the board of directors for Harvard Bio Science and American DG Energy.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq:

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NxStage Announces Presentation of Data at the American Society of Nephrologys Renal Week 2008 Annual Meeting
2. NxStage Reports Second Quarter 2008 Financial Results
3. NxStage Announces $43 Million Private Placement of Equity Securities
4. NxStage Medical Reports First Quarter 2008 Results
5. NxStage Announces Supply Agreement With Kawasumi Laboratories for Blood Tubing Sets
6. Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.
7. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
8. NxStage Medical Reports Fourth Quarter and Full Year 2007 Results
9. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
10. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
11. NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)...olunteer organizations and members of the communit...ystem in West Los Angeles, will once again create ...d to soar to more than 5,000 veterans, active mili... (PRWEB) December 6, 2009 -- Voluntee...ooperation with the Greater VA Healthcare System i...
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
Breaking Medicine News(10 mins):Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2
... When your antidepressant medication does not work... the same class or should you try an antidepressan...ion" This is the question asked by researchers in...oms of major depressive disorder that do not respo...
...esignations, WASHINGTON, March 25 Bridges to Exc...rd physicians for delivering high-quality,care, an...Incentive and,Reward Program Endorsement and the B...E Incentive and Reward,Program Endorsement, the fi...
..., Inc., the leader,in the development of devices f...unced today CE Mark approval for its MitraClip(R) ...ailable device which enables a,non-surgical option...and the second most common in Europe, affecting mi...
...geon General,s national tour to, highlight communi...rograms, PHILADELPHIA, March 25 In the United St...olescents - 17.1 percent of people ages 2,to 19 ye..., high cholesterol and Type 2 diabetes., In an ef...
...yopia or shortsightedness reveals that people who ... , We have literally busted the myth that people ...r personality characteristics. They are more like...lia. , Myopia or shortsightedness is a complex ey...
...erdal Medical,Corporation announces a strategic re...ation. MedAssets Supply Chain Systems has awarded ...tion and Therapy Products." The,contract is effect...ccounts Manager states, "Our,relationship with Med...
Other Medicine News:Health News:Treating SSRI-resistant depression 2Health News:First Health Plans Receive Bridges to Excellence Endorsement and Certification 2Health News:Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 2Health News:Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 3Health News:Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 4Health News:U.S. Surgeon General to Keynote Special Childhood Obesity Prevention Presentation in Philadelphia 2Health News:Mythbusted -- people who wear glasses aren't geeks 2Health News:Laerdal Medical Announces Strategic Relationship 2
(Date:12/4/2009)BILLERICA, Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: VOLC ), today announced the initial development and successful testing of a novel integra
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Medicare Drug Plan Still Needs Work 52454 1Medicare Drug Plan Still Needs Work 52454 2Medicare Drug Plan Still Needs Work 52454 3Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 1Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 2Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 3Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 4Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 5Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 6Schering Plough Announces U S Filing of Mometasone Furoate Formoterol Fumarate Combination for the Maintenance Treatment of Asthma 4767 7NCPA 3A White House Has Ideas on How to Ration Health Care 52448 1NCPA 3A White House Has Ideas on How to Ration Health Care 52448 2
...ral formulation demonstrates 240% improvement in,b...blet and different,absorption characteristics, El...lic Conference Call to discuss results and future ...July 28 Emisphere,Technologies, Inc. (Nasdaq: EM...strating a new, more bioavailable oral form Vitami...
... 28 Cardium Therapeutics,(Amex: CXM ) announced ...edical Officer to lead the Company,s late-stage cl...Repair Company for the MATRIX Phase 2b,clinical st...didate for the,treatment of diabetic ulcers, and t... its Generx product candidate as a potential treat...
Other Medicine Technology:Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation 2Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation 3Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation 4Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 2Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 3Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 4Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities 5
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: